Cortico-saving Treatments Proposed for CLIPPERS: a First Cohort
NCT01740180 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3
Last updated 2018-01-03
Summary
The primary objective of this study is to collect information about how CLIPPERS patients are currently being treated in France.
Conditions
- CLIPPERS
Interventions
- OTHER
-
Data entry
This cohort describes the basic information about the patients (age, sex, weight, height, background) as well as acts required, treatment and results of imaging studies. These data are extracted from patient records by each participating center and collected in an e-CRF.
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nīmes
lead OTHER
Principal Investigators
-
Guillaume Taieb, MD · Centre Hospitalier Universitaire de Nîmes
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-25
- Primary Completion
- 2016-03-25
- Completion
- 2016-03-25
Countries
- France
Study Locations
More Related Trials
-
Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis
NCT03920722 ·Status: COMPLETED ·Phase: PHASE3
-
The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach
NCT01940094 ·Status: COMPLETED ·Phase: PHASE3
-
A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen
NCT04845958 ·Status: COMPLETED
-
Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
NCT01730495 ·Status: TERMINATED ·Phase: PHASE2
-
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
NCT03955445 ·Status: RECRUITING ·Phase: PHASE3
-
Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid
NCT01559155 ·Status: TERMINATED
-
MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis
NCT04244916 ·Status: TERMINATED
-
Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms
NCT03688490 ·Status: COMPLETED
-
The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
NCT01933724 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)
NCT03192969 ·Status: WITHDRAWN ·Phase: PHASE3
-
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Screening for Prognostic Biomarkers of Severe Bell's Palsy in Adults
NCT05582915 ·Status: RECRUITING
-
Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease
NCT03371095 ·Status: COMPLETED ·Phase: PHASE3
-
Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
NCT00315497 ·Status: COMPLETED
-
Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis
NCT04891640 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clusterin, Ptx3 and Pediatric Febrile Neutropenia (CluPPFeN)
NCT05584930 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Severity in Juvenile and Adult-onset Dermatomyositis
NCT06004817 ·Status: RECRUITING
-
Study of Circulating Microparticles in Giant Cell Arteritis
NCT02333708 ·Status: UNKNOWN
-
Quality of Life in Patients With Auto-inflammatory Diseases
NCT03569644 ·Status: COMPLETED ·Phase: NA
-
Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering
NCT04012905 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia.
NCT04057703 ·Status: COMPLETED
-
Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic Syndrome
NCT00577525 ·Status: COMPLETED
-
Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis
NCT02910258 ·Status: COMPLETED
-
Study of Colchicine Resistance in Familial Mediterranean Fever
NCT05418686 ·Status: COMPLETED ·Phase: NA
-
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
NCT00307671 ·Status: COMPLETED ·Phase: PHASE4